The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
The influence of gut microbiota on drug metabolism and toxicity
Open accessAbstract
INTRODUCTION: Gut microbiota plays critical roles in drug metabolism. The variation of gut microbiota contributes to the interindividual differences toward drug therapy including drug-induced toxicity and efficacy. Accordingly, the investigation and elucidation of gut microbial impacts on drug metabolism and toxicity will not only facilitate the way of personalized medicine, but also improve rational drug design. AREAS COVERED: This review provides an overview of the microbiota-host co-metabolism on drug metabolism and summarizes 30 clinical drugs that are co-metabolized by host and gut microbiota. Moreover, this review is specifically focused on elucidating the gut microbial modulation of some clinical drugs, in which the gut microbial influences on drug metabolism, drug-induced toxicity and efficacy are discussed. EXPERT OPINION: The gut microbial contribution to drug metabolism and toxicity is increasingly recognized, but remains largely unexplored due to the extremely complex relationship between gut microbiota and host. The mechanistic elucidation of gut microbiota in drug metabolism is critical before any practical progress in drug design or personalized medicine could be made by modulating human gut microbiota. Analytical technique innovation is urgently required to strengthen our capability in recognizing microbial functions, including metagenomics, metabolomics and the integration of multidisciplinary knowledge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Self-citationMetagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., & Siuzdak, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812874106 · Cited by 2,677
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050
Larson, A. M., Polson, J., Fontana, R. J., Davern, T. J., Lalani, E., Hynan, L. S., Reisch, J. S., Schiødt, F. V., Ostapowicz, G., Shakil, A. O., et al. (2005) · Hepatology · doi:10.1002/hep.20948 · Cited by 1,926
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080
Ghiringhelli, F., Larmonier, N., Schmitt, E., Parcellier, A., Cathelin, D., Garrido, C., Chauffert, B., Solary, E., Bonnotte, B., & Martin, F. (2004) · European Journal of Immunology · doi:10.1002/eji.200324181 · Cited by 880
Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R., & Nicholson, J. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904489106 · Cited by 765
Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
Haiser, H. J., Gootenberg, D. B., Chatman, K., Sirasani, G., Balskus, E. P., & Turnbaugh, P. J. (2013) · Science · doi:10.1126/science.1235872 · Cited by 704 · cited 2×
“lenta 16S rDNA level) and ex vivo digoxin inactivation in healthy volunteers.[9] The elucidation of the mechanisms underlying the gut microbial metabolism on digoxin augments the understanding on gut microbial impacts on pharmacokinetics, and paves the way for clinical application of reducing drug toxicity by manipula…”
BackgroundHuman Sulfotransferases and Their Role in Chemical Metabolism
Gamage, N., Barnett, A., Hempel, N., Duggleby, R. G., Windmill, K. F., Martin, J. L., & McManus, M. E. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj061 · Cited by 703
Diversity of the human gastrointestinal tract microbiota revisited
Rajilić‐Stojanović, M., Smidt, H., & De Vos, W. M. (2007) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01369.x · Cited by 559
Acute liver necrosis following overdose of paracetamol
Davidson, D. G., & Eastham, W. N. (1966) · BMJ · doi:10.1136/bmj.2.5512.497 · Cited by 528
Gut microbiota: a potential new territory for drug targeting
Jia, W., Li, H., Zhao, L., & Nicholson, J. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2505 · Cited by 475
Self-citationInactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy
Lindenbaum, J., Rund, D. G., Butler, V. P., Tse-Eng, D., & Saha, J. R. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110013051403 · Cited by 423 · cited 1×
“[53,54] Moreover, the gut microbial metabolism of digoxin is further demonstrated by the observation that antibiotic pretreatment reduces the secretion of didydrodigoxin in urine and increases the level of digoxin in blood,[11] as well as the identification of digoxin-metabolizing gut bacteria, Eggertherlla lenta.”
BackgroundSchiavoni, G., Sistigu, A., Valentini, M., Mattei, F., Sestili, P., Spadaro, F., Sanchez, M., Lorenzi, S., D'Urso, M. T., Belardelli, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2788 · Cited by 362
Takasuna, K., Hagiwara, T., Hirohashi, M., Kato, M., Nomura, M., Nagai, E., Yokoi, T., & Kamataki, T. (1996) · PubMed · Cited by 336
Irinotecan in the Treatment of Colorectal Cancer: Clinical Overview
Vanhoefer, U., Harstrick, A., Achterrath, W., Cao, S., Seeber, S., & Rustum, Y. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1501 · Cited by 326
Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
Sistigu, A., Viaud, S., Chaput, N., Bracci, L., Proietti, E., & Zitvogel, L. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0245-0 · Cited by 305
Akao, T., Kida, H., Kanaoka, M., Hattori, M., & Kobashi, K. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb03327.x · Cited by 278
Digoxin-Inactivating Bacteria: Identification in Human Gut Flora
Dobkin, J. F., Saha, J. R., Butler, V. P., Neu, H. C., & Lindenbaum, J. (1983) · Science · doi:10.1126/science.6836275 · Cited by 259
Formation of Phenolic and Indolic Compounds by Anaerobic Bacteria in the Human Large Intestine
Smith, E. A., & Macfarlane, G. T. (1997) · Microbial Ecology · doi:10.1007/s002489900020 · Cited by 244
Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations
Barber, M. J., Mangravite, L. M., Hyde, C. L., Chasman, D. I., Smith, J. D., McCarty, C. A., Li, X., Wilke, R. A., Rieder, M. J., Williams, P. T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009763 · Cited by 231
The role of drug metabolizing enzymes in clearance
Di, L. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.876006 · Cited by 206
Stringer, A. M., Gibson, R. J., Logan, R. M., Bowen, J. M., Yeoh, A. S., & Keefe, D. M. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.12.6940 · Cited by 194
Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
Kaddurah-Daouk, R., Baillie, R. A., Zhu, H., Zeng, Z.-B., Wiest, M. M., Nguyen, U. T., Wojnoonski, K., Watkins, S. M., Trupp, M., & Krauss, R. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025482 · Cited by 193
Developing a metagenomic view of xenobiotic metabolism
Haiser, H. J., & Turnbaugh, P. J. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.07.009 · Cited by 186 · cited 3×
“Gut microbiota can influence drug metabolism through several proposed ways including production of microbial metabolites to interfere with drug metabolism,[8] production of microbial enzymes to transform drug molecules,[9,10] and modification of drug-metabolizing genes or enzymes in host liver or intestine tissues.[7]…”
BackgroundInfluentialCyclophosphamide Induces Differentiation of Th17 Cells in Cancer Patients
Viaud, S., Flament, C., Zoubir, M., Pautier, P., LeCesne, A., Ribrag, V., Soria, J.-C., Marty, V., Vielh, P., Robert, C., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1259 · Cited by 170
Saad, R., Rizkallah, M. R., & Aziz, R. K. (2012) · Gut Pathogens · doi:10.1186/1757-4749-4-16 · Cited by 164
Gut microbiota-mediated drug interactions between lovastatin and antibiotics
Yoo, D.-H., Kim, I. S., Van Le, T. K., Jung, I.-H., Yoo, H. H., & Kim, D.-H. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058354 · Cited by 158
Matthies, A., Clavel, T., Gütschow, M., Engst, W., Haller, D., Blaut, M., & Braune, A. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00555-08 · Cited by 141
Matthies, A., Loh, G., Blaut, M., & Braune, A. (2011) · Journal of Nutrition · doi:10.3945/jn.111.148247 · Cited by 139
The effect of gut microbiota on drug metabolism
Kang, M. J., Kim, H. G., Kim, J. S., Oh, D. G., Um, Y. J., Seo, C. S., Han, J. W., Cho, H. J., Kim, G. H., Jeong, T. C., et al. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.807798 · Cited by 130
Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora
Harris, B., Manning, B. W., Federle, T. W., & Diasio, R. B. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.1.44 · Cited by 128
Nakayama, H., Kinouchi, T., Kataoka, K., Akimoto, S., Matsuda, Y., & Ohnishi, Y. (1997) · Pharmacogenetics · doi:10.1097/00008571-199702000-00005 · Cited by 120
Wadworth, A. N., & Fitton, A. (1991) · Drugs · doi:10.2165/00003495-199141040-00009 · Cited by 110
Antiallergic Activity of Hesperidin Is Activated by Intestinal Microflora
Lee, N.-K., Choi, S., Park, S., Park, E.-K., & Kim, D.-H. (2004) · Pharmacology · doi:10.1159/000078083 · Cited by 106
Bacterial Inactivation of the Anticancer Drug Doxorubicin
Westman, E. L., Canova, M. J., Radhi, I. J., Koteva, K. K., Kireeva, I., Waglechner, N., & Wright, G. D. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.08.011 · Cited by 104
The Fermentation of Lactulose by Colonic Bacteria
Sahota, S. S., Bramley, P. M., & Menzies, I. S. (1982) · Microbiology · doi:10.1099/00221287-128-2-319 · Cited by 101
Akao, T., Hayashi, T., Kobashi, K., Kanaoka, M., Kato, H., Kobayashi, M., Takeda, S., & Oyama, T. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03756.x · Cited by 100
The anaerobic metabolism of metronidazole forms N-(2-hydroxyethyl)-oxamic acid.
Koch, R. L., & Goldman, P. (1979) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31588-0 · Cited by 97
Role of metabolism by intestinal microbiota in pharmacokinetics of oral baicalin
Kang, M. J., Ko, G. S., Oh, D. G., Kim, J. S., Noh, K., Kang, W., Yoon, W. K., Kim, H. C., Jeong, H. G., & Jeong, T. C. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0179-2 · Cited by 94
Cometabolism of Microbes and Host: Implications for Drug Metabolism and Drug-Induced Toxicity
Li, H., & Jia, W. P. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.157 · Cited by 94
Self-citationDrugs, bugs, and personalized medicine: Pharmacometabonomics enters the ring
Wilson, I. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907721106 · Cited by 92
CONTRIBUTIONS OF HOST AND INTESTINAL MICROFLORA IN THE METABOLISM OF l-DOPA BY THE RAT
Goldin, B. R., Peppercorn, M. A., & Goldman, P. (1973) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29577-5 · Cited by 91
Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria
Schneider, H., Simmering, R., Hartmann, L., Pforte, H., & Blaut, M. (2000) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2000.01209.x · Cited by 87
Basit, A. W., Newton, J. M., & Lacey, L. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00018-2 · Cited by 81
THE BACTERIAL DEGRADATION OF CHLORAMPHENICOL
HOLT, R. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92720-1 · Cited by 80
In Vitro Fermentation of Lactulose by Human Gut Bacteria
Mao, B., Li, D., Zhao, J., Liu, X., Gu, Z., Chen, Y. Q., Zhang, H., & Chen, W. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf503484d · Cited by 73
The metabolism and excretion of risperidone after oral administration in rats and dogs.
Meuldermans, W., Hendrickx, J., Mannens, G., Lavrijsen, K., Janssen, C., Bracke, J., Jeune, L. L., Lauwers, W., & Heykants, J. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08286-8 · Cited by 73
Takeno, S., & Sakai, T. (1991) · Teratology · doi:10.1002/tera.1420440209 · Cited by 72
Anti-pruritic effect of baicalin and its metabolites, baicalein and oroxylin A, in mice
Trinh, H.-T., Joh, E., Kwak, H.-Y., Baek, N., & Kim, D. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.42 · Cited by 71
Jin, M. J., Kim, U., Kim, I., Kim, Y., Kim, D., Han, S. B., Kim, D., Kwon, O., & Yoo, H. H. (2010) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2010.511549 · Cited by 70
The reduction of sulphinpyrazone and sulindac by intestinal bacteria
Strong, H. A., RENWICK, A. G., George, C. F., Liu, Y. F., & Hill, M. J. (1987) · Xenobiotica · doi:10.3109/00498258709043976 · Cited by 70
Shim, S.-B., Kim, N. J., & Kim, D.-H. (2000) · Planta Medica · doi:10.1055/s-2000-11109 · Cited by 66
Tralau, T., Sowada, J., & Luch, A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.990437 · Cited by 62
Lavrijsen, K., Dyck, D. V., Houdt, J. V., Hendrickx, J., Monbaliu, J. G., Woestenborghs, R. J. H., Meuldermans, W., & Heykants, J. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06545-6 · Cited by 59
Pharmacogenomics of Statin Responsiveness
Kajinami, K., Akao, H., Polisecki, E. Y., & Schaefer, E. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.011 · Cited by 59
Metabolism of levamisole, an anti-colon cancer drug, by human intestinal bacteria
Shu, Y. ‐., Kingston, D. G. I., Tassell, R. L. V., & Wilkins, T. D. (1991) · Xenobiotica · doi:10.3109/00498259109039513 · Cited by 56
The demethylation of methamphetamine by intestinal microflora
Caldwell, J., & HAWKSWORTH, G. M. (1973) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1973.tb10043.x · Cited by 54
Drug metabolome of the Simvastatin formed by human intestinal microbiota in vitro
Aura, A., Mattila, I. M., Hyötyläinen, T., Gopalacharyulu, P. V., Bounsaythip, C., Orešič, M., & Oksman‐Caldentey, K. (2010) · Molecular BioSystems · doi:10.1039/c0mb00023j · Cited by 54
The role of intestinal microbiota in murine models of acetaminophen‐induced hepatotoxicity
Possamai, L. A., McPhail, M. J. W., Khamri, W., Wu, B., Concas, D., Harrison, M., Williams, R. L., Cox, R., Cox, I. J., Anstee, Q. M., et al. (2014) · Liver International · doi:10.1111/liv.12689 · Cited by 53
Metabolism of Omeprazole by Gut Flora in Rats
Watanabe, K., Yamashita, S., Furuno, K., Kawasaki, H., & Gomita, Y. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840425 · Cited by 44
Investigation of Host–Gut Microbiota Modulation of Therapeutic Outcome
Yip, L. Y., & Chan, E. C. Y. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.063750 · Cited by 43
Vick, R. L., Kahn, J. B., & Acheson, G. H. (1957) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11953-8 · Cited by 43
Evaluation of pharmacokinetic differences of acetaminophen in pseudo germ‐free rats
Lee, S. H., An, J. H., Lee, H. J., & Jung, B. H. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1799 · Cited by 32
Mikov, M., Caldwell, J., Dolphin, C. T., & Smith, R. L. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90005-6 · Cited by 27
Pharmacogenomics: Historical Perspective and Current Status
Charlab, R., & Zhang, L. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-435-7_1 · Cited by 26
Metabolism of peptide drugs by the microorganisms in rat cecal contents.
Tozaki, H., Yasuharu, E. M. I., Horisaka, E., FUJITA, T., Yamamoto, A., & Muranishi, S. (1995) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.18.929 · Cited by 24
THE RELATIONSHIP BETWEEN THE STRUCTURE AND THE BIOLOGICAL ACTION OF THE CARDIAC GLUCOSIDES
Jacobs, W. A., & Hoffmann, A. (1927) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)74067-6 · Cited by 23
Cited by
Gut microbiota modulation of chemotherapy efficacy and toxicity
Alexander, J. L., Wilson, I. D., Teare, J., Marchesi, J. R., Nicholson, J. K., & Kinross, J. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.20 · Cited by 970
“However, the gut microbiota also have a major role in defining the efficacy and toxicity of a broad range of drugs 13,14 .”
The interaction among gut microbes, the intestinal barrier and short chain fatty acids
Ma, J., Piao, X., Mahfuz, S., Long, S., & Wang, J. (2022) · Animal Nutrition · doi:10.1016/j.aninu.2021.09.012 · Cited by 398
Gut microbiota, a new frontier to understand traditional Chinese medicines
Feng, W., Ao, H., Peng, C., & Yan, D. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.024 · Cited by 377
Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 359
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Metadata
- Authors
- Li, H., He, J., & Jia, W.
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2015-12-10
- Volume
- 12
- Issue
- 1
- Pages
- 31-40
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2214503903
- Cited by
- 278
- References
- 75
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.